Guyana vs Nepal: Cause of death, by non-communicable diseases, ages 0-4, male
Guyana
21.6%
in 2021
Nepal
18.9%
in 2021
Guyana rank
124th
Nepal rank
125th
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Guyana
- Nepal
How they compare
Guyana currently reports 21.6% against 18.9% in Nepal, a difference of 2.7%.
That makes Guyana's figure about 1.1 times Nepal's.
Across all 6 years both countries report, Guyana has been ahead every year.
Guyana ranks 124th and Nepal ranks 125th of 185 countries.
Guyana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guyana | Nepal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.6% | 7.3% | 8.3% | Guyana |
| 2010s | 21.3% | 13.7% | 7.6% | Guyana |
| 2020s | 21.6% | 18.6% | 3.0% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Guyana or Nepal?
- Guyana, at 21.6% against 18.9% in Nepal as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Guyana and Nepal?
- 2.7%, with Guyana ahead.
- How many years of comparable data are there for Guyana and Nepal?
- 6 years are reported by both, from 2000 to 2021.
- How do Guyana and Nepal rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Guyana ranks 124th and Nepal ranks 125th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.